PUBLISHER: The Business Research Company | PRODUCT CODE: 1945603
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945603
Microarray scanners play a crucial role in molecular biology and genetics research, specifically for the analysis of microarrays. Microarrays are arrays of microscopic spots containing immobilized DNA, RNA, proteins, or other molecules on solid surfaces such as glass slides or silicon chips. These scanners are utilized to measure the fluorescent regions of DNA microarrays, providing detailed insights into the simultaneous activity of numerous genes.
The primary product categories of microarray scanners include fluorescence microarray scanners, charge-coupled device microarray scanners, colorimetric microarray scanners, and others. Fluorescence microarray scanners are specialized instruments designed for the detection and capture of fluorescent signals emitted by molecules labeled with fluorescence on microarrays. Microarray scanners utilize various technologies, including slide-based and gel-based approaches, with applications spanning gene expression, drug discovery, and more. The end users of these scanners are diverse and include hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, as well as academic and research institutes.
Tariffs are impacting the microarray scanners market by increasing costs of imported optical components, lasers, sensors, electronic modules, and precision manufacturing equipment. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on imported high-end scanners, while Asia-Pacific faces cost pressures on exported research instruments. These tariffs are increasing capital expenditure for laboratories and delaying equipment upgrades. However, they are also encouraging regional manufacturing, localized component sourcing, and development of cost-optimized microarray scanning solutions.
The microarray scanners market research report is one of a series of new reports from The Business Research Company that provides microarray scanners market statistics, including microarray scanners industry global market size, regional shares, competitors with a microarray scanners market share, detailed microarray scanners market segments, market trends and opportunities, and any further data you may need to thrive in the microarray scanners industry. This microarray scanners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The microarray scanners market size has grown strongly in recent years. It will grow from $1 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to expansion of genomics research activities, growth in academic and research funding, increasing use of microarray technologies, rising demand for gene expression analysis, advancements in fluorescence detection methods.
The microarray scanners market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of precision medicine research, rising investments in biotechnology and pharmaceutical R&D, expansion of large-scale genomic studies, growing integration of ai-driven data analysis, increasing demand for high-throughput research tools. Major trends in the forecast period include increasing adoption of high-resolution fluorescence scanners, rising use in genomic and proteomic research, growing integration with data analysis software, expansion of automated sample processing, enhanced focus on multiplex detection.
The anticipated growth in the microarray scanner market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or more and having the potential to worsen over time, can be effectively studied using microarray scanners. These devices enable the assessment of gene expression patterns, allowing researchers to delve into the molecular mechanisms underlying chronic diseases and identify potential biomarkers for diagnosis, prognosis, and treatment. According to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant increase from 71.522 million in 2020. Thus, the growing prevalence of chronic diseases is a key driver for the expansion of the microarray scanner market.
Major companies operating in the microarray scanners market are focusing on the development of innovative products, such as advanced microarray platforms, to maintain their competitive position in the market. An advanced microarray platform is a high-throughput technology that allows the simultaneous analysis of thousands of genes, proteins, or biomarkers on a single chip, offering improved sensitivity, specificity, and data accuracy. For example, in June 2023, MARGenomics Private Ltd., a Spain-based company, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform representing a significant advancement in microarray technology. The platform is notable for being the first in Europe and the United States to obtain regulatory approval for diagnostic use, highlighting its potential impact on clinical diagnostics and research. With its capability to deliver high-resolution genomic data, the system is expected to support and advance personalized medicine approaches across multiple therapeutic areas.
In May 2024, New York Blood Center Enterprises (NYBCe), a United States-based healthcare and biotechnology research organization, entered into a partnership with Thermo Fisher Scientific. Through this collaboration, the two organizations sought to jointly develop the Applied Biosystems Axiom BloodGenomiX Array and Reporter Software, a next-generation, high-throughput solution designed to enable more accurate blood genotyping and improve transfusion safety. Thermo Fisher Scientific is a United States-based technology and life sciences company.
Major companies operating in the microarray scanners market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Hitachi High-Tech Corporation, Innopsys Inc., PerkinElmer Inc., VWR International LLC, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Tecan Group AG, Huron Technologies International Inc., Miltenyi Biotec B.V. & Co. KG, Luminex Corporation, Molecular Devices LLC, CapitalBio Technology Inc., Berthold Technologies GmbH & Co. KG, RayBiotech Inc., Scienion AG, Oxford Gene Technology IP Limited, Applied Microarrays Inc., Arrayit Corporation
North America was the largest region in the microarray scanners market in 2025. The regions covered in the microarray scanners market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the microarray scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The microarray scanners market consists of sales of microarray slides, microarray printing and labeling kit, microarray scanners software and analysis tools, and microarray wash stations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Microarray Scanners Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses microarray scanners market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for microarray scanners ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microarray scanners market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.